Universitätsklinikum Frankfurt Medizinische Klinik 2: Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie/HIV
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wolf, Timo
PREPARE, NCT05959421: Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure

Not yet recruiting
3
70
Europe
ERVEBO® (rVSV∆G-ZEBOV-GP)
Universitätsklinikum Hamburg-Eppendorf, Bernhard Nocht Institute for Tropical Medicine, Goethe University, German Federal Ministry of Education and Research, Monipol Deutschland GmbH
Ebola Vaccine
03/26
02/27
NECTAR, NCT05593770 / 2022-000715-31: International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

Terminated
2/3
28
Europe, RoW
Fostamatinib, Placebo
NEAT ID Foundation, National Institutes of Health (NIH)
COVID-19, SARS-CoV2 Infection, Coronavirus Infection
12/23
12/23
RECOVER, NCT05200754: Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

Recruiting
2
174
Europe
Convalescent/Vaccine-boosted Plasma (CP/PVP)
Carsten Müller-Tidow, German Federal Ministry of Education and Research, Institut für Klinische Transfusionsmedizin und Zelltherapie Heidelberg gGmbH
SARS-CoV-2 Infection
04/22
06/22

Download Options